Articles related to SCHIZOPHRENIA

Recent advancements in the treatment of acute agitation offer promising non-invasive options, such as inhaled loxapine and sublingual dexmedetomidine, aligning with the shift towards patient-centered care and minimizing the use of coercive measures.

The JEWEL study has demonstrated that lurasidone treatment in patients with schizophrenia results in significant improvements in social functioning, with notable progress observed from the early stages of treatment and sustained benefits over a 12-week extension period.

In an exciting development for schizophrenia research, Dr. Pan Li’s team utilizes CRISPR/Cas9 to explore neuron cell development, focusing on rare gene variants.

This meta-analysis highlights a significant association between cat ownership and an increased risk of schizophrenia-related disorders, emphasizing the need for further exploration of environmental factors in mental health.

Explore groundbreaking therapies in the pipeline: Onivyde for pancreatic cancer, showing marked survival benefits, and roluperidone, offering new hope in managing schizophrenia’s negative symptoms.

Explore the latest advances in schizophrenia research and understand how TAAR1 agonism could potentially change the treatment paradigm. Join us in this educational journey.